Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
6,699,021
-
Share change
-
+3,683,381
-
Total reported value
-
$28,349,600
-
Price per share
-
$4.24
-
Number of holders
-
28
-
Value change
-
+$15,565,685
-
Number of buys
-
22
-
Number of sells
-
2
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q3 2020
As of 30 Sep 2020,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,699,021 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, Point72 Asset Management, L.P., Nantahala Capital Management, LLC, Corriente Advisors, LLC, Granite Point Capital Management, L.P., Manatuck Hill Partners, LLC, Ikarian Capital, LLC, Maven Securities LTD, VANGUARD GROUP INC, and CVI Holdings, LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.